You have 9 free searches left this month | for more free features.

Moderna

Showing 1 - 25 of 236

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19
  • mRNA-1273
  • Pasadena, California
    Kaiser Permanente Southern California
Jul 5, 2023

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Active, not recruiting
  • Coronavirus Disease (COVID-19)
  • COVID-19 Vaccine
  • Tokyo, Japan
    Moderna selected site
Jan 12, 2023

Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

Completed
  • Healthy
  • Chronic Stable Illness
  • Little Rock, Arkansas
  • +5 more
Jan 9, 2023

Post Authorization Safety Study Moderna COVID-19 Primary Vaccine

Completed
  • COVID-19
  • Moderna COVID-19 Vaccine
  • Jakarta Pusat, Jakarta, Indonesia
  • +17 more
Aug 22, 2023

Moderna COVID-19 Vaccine in People at High-Risk of Developing

Withdrawn
  • Coronavirus Disease (COVID-19)
  • COVID-19 Vaccine
  • Tokyo, Japan
    Takeda Selected Site
Jul 25, 2022

Vaccine Response Impaired, Immune Suppression, Covid19 Trial in Toronto (mRNA-1273 vaccine, Normal Saline Placebo)

Completed
  • Vaccine Response Impaired
  • +2 more
  • mRNA-1273 vaccine
  • Normal Saline Placebo
  • Toronto, Ontario, Canada
  • +1 more
Jul 29, 2022

COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)

Not yet recruiting
  • COVID-19
  • Bivalent Moderna
  • Novavax
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023

COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

Not yet recruiting
  • COVID-19
  • Pfizer-BioNTech Standard dose
  • +5 more
  • Bandung, West Java, Indonesia
  • +2 more
Nov 30, 2022

COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

Not yet recruiting
  • COVID-19
  • Tozinameran
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital, Murdoch Children's Research Institute
Sep 14, 2022

Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))

Active, not recruiting
  • Lung Transplant Recipient
  • +2 more
  • mRNA-1273 (Moderna COVID-19 vaccine)
  • Los Angeles, California
    UCLA Clinical Translational Research Center
Dec 13, 2022

COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

Active, not recruiting
  • COVID-19
  • Tozinameran - Standard dose
  • +3 more
  • Melbourne, Victoria, Australia
    Royal Children's Hospital
Aug 24, 2022

HIV, Organ Transplantation, Lymphoma, Non-Hodgkin Trial in Melbourne (Pfizer Bivalent COVID-19 Vaccine, Moderna Bivalent mRNA

Recruiting
  • HIV
  • +5 more
  • Pfizer Bivalent COVID-19 Vaccine
  • Moderna Bivalent mRNA vaccine
  • Melbourne, Victoria, Australia
    Alfred Health
Jan 31, 2023

SARS CoV 2 Infection, COVID-19 Trial in Brownsville, Edinburg, Rio Grande City (Pfizer/BioNTech (BNT162b2), Moderna)

Recruiting
  • SARS CoV 2 Infection
  • COVID-19
  • Pfizer/BioNTech (BNT162b2)
  • Moderna
  • Brownsville, Texas
  • +3 more
Mar 14, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Risk Factors of Myocarditis and Pericarditis After Moderna

Active, not recruiting
  • Myocarditis, Pericarditis
  • mRNA-1273
  • Aarhus, Denmark
  • +4 more
Oct 31, 2023

COVID-19, Vaccine Reaction, COVID-19 Pandemic Trial in San Francisco (Moderna Booster Vaccine, Pfizer Booster Vaccine)

Enrolling by invitation
  • COVID-19
  • +2 more
  • Moderna Booster Vaccine
  • Pfizer Booster Vaccine
  • San Francisco, California
    UCSF Parnassus
Mar 1, 2022

The Impact of COVID-19 on Maternal and Neonatal Outcomes

Recruiting
  • COVID-19
  • Pregnancy; Infection
  • mRNA COVID-19 vaccine (Pfizer or Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jan 14, 2022

Antenatal COVID 19 Vaccination and Pregnancy Outcomes

Recruiting
  • Effect of Drug
  • pfizer, astrazeneca,moderna,sinofac
  • Cairo, Egypt
    Ainshams university
Jun 1, 2022

Kidney Transplant Recipients Trial in Baltimore (mRNA-1273 vaccine (Pfizer/BioNTech), mRNA-1273 vaccine (Moderna))

Active, not recruiting
  • Kidney Transplant Recipients
  • mRNA-1273 vaccine (Pfizer/BioNTech)
  • mRNA-1273 vaccine (Moderna)
  • Baltimore, Maryland
    Johns Hopkins Hospital
Oct 4, 2021

COVID-19, SARS-CoV-2 Infection Trial (SCTV01C, SCTV01E, mRNA vaccine manufactured by Pfizer or Moderna)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • SCTV01C
  • +3 more
  • (no location specified)
Apr 1, 2022

Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose Trial in Paris

Active, not recruiting
  • Adult Who Received a First Dose of an mRNA Vaccine (Pfizer-BioNTech or Moderna) and Need to Receive a Second Dose
  • Pfizer
  • Moderna
  • Paris, France
    CIC 1417 Cochin-Pasteur
Jul 31, 2021

SARS-CoV Infection Trial in Denmark (COMIRNATY - BioNTech Manufacturing GmbH, COVID-19 Vaccine Moderna dispersion for injection

Recruiting
  • SARS-CoV Infection
  • COMIRNATY - BioNTech Manufacturing GmbH
  • +2 more
  • Aarhus, Aarhus N, Denmark
  • +4 more
Apr 11, 2022

Oncology Patients to Novel Coronavirus Vaccines (IROC)

Recruiting
  • Cancer
  • COVID-19 Vaccination
  • Carmel, Indiana
  • +1 more
Aug 2, 2022

Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine

Active, not recruiting
  • Immunocompromised Patients
  • Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
  • Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
  • Basel, Switzerland
  • +3 more
Oct 18, 2022